Background -Total IgE concentrations are higher in dogs than in humans. Persistent Toxocara canis larval infection is prevalent in dogs and is associated with substantial specific antibody reactions. A correlation, however, between total IgE and T. canis-specific antibody levels in dogs has not been evaluated.
Introduction
Immunoglobulin E (IgE) is associated with atopic disease and parasitic infection. 1 IgE antibodies can, however, be expressed in the absence of antigen stimulation. Total IgE is composed of IgE from three different origins: IgE produced independent of T-cell signalling; parasite-specific IgE produced subsequent to host-parasite interaction; and allergen-specific IgE produced subsequent to specific sensitization in predisposed individuals. 2 Canine atopic dermatitis (cAD) is a common, chronic and pruritic inflammatory skin disease of dogs. 3 The diagnosis is based on history, clinical signs and the elimination of other causes of pruritus. 4 Although cAD can be associated with high levels of allergen-specific IgE, serological allergen tests are not recommended for the diagnosis because healthy dogs can have elevated allergen-specific IgE levels. [5] [6] [7] In humans, increased total serum IgE level can be a useful marker for the confirmation of atopy especially in children from industrialized countries. Elevations of total IgE levels greater than 0.24 lg/mL or 0.54 lg/mL are considered consistent with the diagnosis of atopic disease. 8, 9 Non-atopic humans infected with endoparasites, however, also can exhibit very high total IgE levels. For example, humans infected with Toxocara canis can exhibit total serum IgE levels >1.2 lg/mL. 10, 11 Total IgE concentrations in healthy dogs are much higher compared to healthy humans. 12 The maximum total IgE level in healthy dogs ranges from 0.5 to 505 lg/ mL (Table 1 ). Higher levels of total IgE in dogs compared to humans could be associated with more frequent helminth infections of dogs. 13, 14 Toxocara canis is a common intestinal nematode of dogs; [15] [16] [17] it can cause high total IgE levels in infected humans. 10, 11 The prevalence of patent T. canis infection in dogs depends on various factors (age, origin, locality of the dog) and varies from 3 to 34% in Europe. [18] [19] [20] [21] [22] [23] Furthermore, the prevalence of dogs with T. canis-specific antibodies to larval excretory/ secretory (E/S) antigen is much higher. This arises from infection with persistent T. canis larvae in the absence of patent infection at the time of evaluation. 24 It is well established that total IgE concentration does not correlate with the development of atopic dermatitis in dogs. There is either no difference between total IgE values between atopic and healthy dogs or levels can be higher in healthy dogs (Table 1) . It has been proposed that helminth infection and/or helminth-specific IgG or IgE antibodies may play a protective role against the development of cAD. This could potentially explain why, in some studies, healthy dogs have a higher total serum IgE concentration compared to atopic dogs.
In the present study, the interaction between total IgE, T. canis-specific IgG and T. canis-specific IgE levels in the sera of atopic and non-atopic dogs was evaluated. In addition, the influence of these antibody levels on allergenspecific IgE values and various confounding factors affecting total IgE and T. canis-specific IgG and IgE levels were evaluated.
Materials and methods

Animals
The study was performed using sera collected consecutively from 60 (30 atopic and 30 non-atopic) dogs presenting to the dermatology unit at the Vetsuisse Faculty, University of Zurich. The diagnosis of atopic dermatitis was based on each dog fulfilling at least five criteria, after ectoparasite infections and bacterial or yeast dermatitis were excluded. 36 To confirm or exclude food-induced atopic dermatitis (FIAD), an elimination diet was conducted and dogs that demonstrated an improvement during the trial were challenged with the previously fed foods. If the clinical signs improved during the dietary trial and relapsed upon food challenge, then FIAD was confirmed. If the dog did not respond to the elimination diet or demonstrated only a partial improvement of the clinical signs, an intradermal test with Greer allergens (Greer Veterinary Laboratories; Lenoir, NC, USA) and/ or a serological allergen test (Allerceptᵀᴹ system, Heska AG; Fribourg, Switzerland) was performed. For each serum sample collected from an atopic dog, a control serum sample from a healthy donor of similar age and breed (using the breed group and section as designated by the F ed eration Cynologique Internationale; http://www.fci.be/en/) was collected ( Table 2 ).
The control dogs had no history of allergic skin disease or any other disease affecting the immune system and were not receiving any immunomodulatory drugs (ciclosporin, glucocorticoids or oclacitinib).
Factors influencing total IgE and Toxocara canis L3 E/ S-specific antibodies
Age, sex, frequency of deworming, vaccination status, estrous cycle phase, season of sample collection, concurrent immunomodulatory treatment and cause of the atopic disease (i.e. food or environmental allergens) was recorded for each dog. Samples collected during the months with low pollen loads (October to March) were compared to those collected during months with higher pollen loads (April to September) to determine the effect of seasonal influence. Dogs dewormed at least four times a year and less than three months prior to serum collection were compared to the dogs not fulfilling these criteria. Within the group of atopic animals, the dogs treated with systemic immunomodulatory drugs (ciclosporin, glucocorticoids, oclacitinib) were compared to dogs receiving no treatment or only topical medication. Additionally, the dogs treated with allergen-specific immunotherapy (ASIT) were compared to the dogs that did not receive ASIT.
Determination of total IgE
Total serum IgE concentrations were evaluated using a commercial dog IgE ELISA quantitation kit (Bethyl Laboratories; Montgomery, AL, USA). To validate these data, ten additional dog sera analysed in a previous study were measured using this ELISA methodology and the results compared. 35 The measured total IgE concentrations were comparable with a correlation of r = 0.95 and a paired t-test P-value of 0.75 (data not shown).
Determination of Toxocara canis L3 E/S-specific IgG
IgG antibodies against larval T. canis E/S antigen were evaluated using a method described previously. 24 Toxocara canis L3 E/S anti- On each plate, we included five negative control sera of specific pathogen free (SPF) dogs and two positive control sera of dogs with proven T. canis infection, to allow the interassay calibration. The cutoff for T. canis larval E/S-specific IgG at OD <0.026 was determined by a receiver operating characteristic (ROC) curve.
Determination of Toxocara canis L3 E/S-specific IgE
IgE-specific antibodies against larval T. canis E/S antigen were evaluated using a similar methodology: plates were coated, blocked and sampled as described above for T. canis L3 E/S-specific IgG analysis. For detection of IgE levels, a biotinylated anti-canine IgE monoclonal antibody 5.91 (provided by Bruce Hammerberg, North Carolina State University, Raleigh, NC, USA) in a 0.25 lg/mL dilution with PBS containing 0.05% Tween 20 (PBS-T) was added for 2 h at 37°C. Following washing, alkaline phosphatase-conjugated streptavidin (Thermo Scientific; Waltham, MA, USA) was added at a dilution of 1:5,000 in PBS-T and incubated for 1 h at 37°C. After a final wash, the plates were developed as described above and after 5 min, the OD values were read at 405 nm. 
Determination of allergen-specific IgE
Allergen-specific IgE levels in sera samples from 20 atopic and 13 non-atopic dogs were measured by Heska AG in Fribourg, Switzerland. The remaining sera of 10 atopic and 17 non-atopic dogs were not analysed due to insufficient serum quantities. The allergen-specific IgE concentrations for 48 different antigens were measured with the Heska Allerceptᵀᴹ system and expressed in Heska Epsilon Receptor Binding Units (HERBUs). 37 For each dog the HERBUs of the 48 allergens were added to calculate the individual sum of allergen-specific IgE. These allergen-specific IgE sums were then compared to the total IgE concentrations in both groups. In addition, the ratio of allergen-specific IgE sum to total IgE concentration was calculated for each dog. These ratios, as well as the Dermatophagoides farina (Df)-and Dermatophagoides pteronyssinus (Dp)-specific IgE values, were compared between the atopic and non-atopic group.
Statistical methods
Statistical analyses were conducted using SPSS v22.0 (IBM Corp; Armonk, NY, USA). The Kolmogorov test demonstrated that the total IgE, T. canis-specific IgG and IgE, and allergen-specific IgE values were not normally distributed. A nonparametric test (Spearman's rank correlation coefficient) was therefore used to evaluate the correlations between the antibody levels. ANOVA was used to compare the antibody levels between the atopic and non-atopic dogs, and to determine the correlations between the antibody levels and various confounding factors, such as age, gender, deworming, season and vaccination status. Following ANOVA, a post hoc Student's t-test was conducted. When a statistically significant difference was detected, a Wilcoxon-Mann-Whitney U-test was additionally performed for confirmation. The level of significance was set at P < 0.05.
Results
Study population
Thirty atopic (male:female ratio 14:16; mean age 6.2 years) and 30 non-atopic (male:female ratio 9:20; mean age 6 years) dogs were included (Table 2 ). Of 30 atopic dogs, 18 were diagnosed with cAD and 10 with FIAD. In five dogs with FIAD, the clinical signs did not resolve completely during dietary restriction. Furthermore, in two dogs the incriminated allergens were not identified because the elimination diet was not completed and environmental allergen testing was negative.
Total IgE
The total IgE concentrations were overall very high and significantly (Student's t-test, P = 0.02; Wilcoxon-MannWhitney U-test, P = 0.002) increased in the non-atopic (range 0.4-412.1 lg/mL, mean 64.5 lg/mL, median 47.3 lg/mL; Table 3 ) compared to the atopic dogs (range 0.5-120.8 lg/mL, mean 22.6 lg/mL, median 12.3 lg/ mL; Table 3 ). There was a wide range of total IgE in the atopic and non-atopic dogs, with overlap in the levels between the groups. (Table 3) .
Toxocara canis L3 E/S-specific IgG
Toxocara canis-specific IgG values above the cut-off were detected in 83.3% (25 of 30) of the atopic and 96.7% (29 of 30) of the non-atopic dogs. In non-atopic individuals the OD values ranged from 0.02 to 1.22 (mean 0.47, median 0.42; Table 3 ) and in atopic dogs from 0.01 to 0.88 (mean 0.21, median 0.13; Table 3 ). This difference was statistically significant (Student's t-test, P = 0.004; WilcoxonMann-Whitney U-test, P = 0.004).
Toxocara canis L3 E/S-specific IgE
Toxocara canis-specific IgE values were significantly higher (Student's t-test, P = 0.04; Wilcoxon-Mann-Whitney U-test, P = 0.002) in non-atopic (range 0.01-2.19, mean 0.32, median 0.14; Table 3 ) than in atopic dogs (range 0.01-0.99, mean 0.11, median 0.03; Table 3 ).
Correlations between total IgE and Toxocara canis L3 E/S-specific antibodies
There was a significant (P = 0.01) positive correlation between T. canis-specific IgG and T. canis-specific IgE (76%), T. canis-specific IgG and total IgE (53%), as well as T. canis-specific IgE and total IgE (76%) in atopic and non-atopic dogs.
Factors influencing total IgE and Toxocara canis L3 E/S-specific antibodies
There were no statistically significant differences in total IgE concentrations or T. canis-specific IgG and IgE levels within the atopic and non-atopic groups with respect to age, gender, frequency of deworming, vaccination status and season of sample collection. Additionally, there was no association with the presence of FIAD, immunomodulatory drug therapy or recent desensitization within the atopic group. All the dogs with very high total IgE values had been dewormed at least four times a year and less than three months before blood collection. Five dogs from the non-atopic group (dogs 33, 39, 43, 48 and 58) were in estrus at the time of blood collection, but only one (Dog 58) had a high total IgE concentration (see Table S1 ).
Allergen-specific IgE
The total allergen-specific IgE levels were significantly (P = 0.027) higher in the non-atopic (range 29-5,896 HERBU, mean 2,163 HERBU, median 2,314 HERBU; Table 3 ) than the atopic dogs (range 1-4,557 HERBU, mean 1,072 HERBU, median 602 HERBU; Table 3 ). Furthermore, a positive correlation between total IgE concentration and the sum of all allergen-specific IgE (r = 0.56, P = 0.002) was evident in both groups. Conversely, there was no statistically significant difference in the ratio of total allergen-specific IgE to total IgE concentration or the Df-and Dp-specific IgE concentrations between atopic and non-atopic dogs.
Discussion
This study demonstrates that levels of total IgE, T. canisspecific IgG, T. canis-specific IgE and allergen-specific IgE are significantly increased in healthy dogs compared to dogs with cAD. Furthermore, T. canis-specific IgE levels correlated with total IgE concentrations, suggesting that T. canis-specific IgE is a major component of total IgE in dogs. Serum total IgE levels have been evaluated in healthy dogs. Canine total IgE concentrations reportedly range from undetectable to 505 lg/mL (Table 1 ) with values progressively increasing over time. In 1997, IgE levels in the range of <0.0005-2 lg/mL were reported, whereas 15 years later, the range was higher at 0.5-505 lg/ mL. 27, 35 Dogs usually have higher total serum IgE concentrations than humans. 12 This could be explained by the natural behaviour of dogs during daily outdoor activities, and the more frequent exposure to and infection with parasites, particularly nematodes. 13, 14 This study demonstrated that 90% of dogs, including those undergoing regular deworming, had a positive T. canis-specific IgG value. This suggests that dogs in Switzerland have sufficient exposure to T. canis to develop an antibodymediated immune response. Given that the majority of dogs with a positive T. canis-specific IgG value also had an increased T. canis-specific IgE value, and that T. canisspecific IgE and total IgE levels positively correlated, our results could suggest that T. canis-specific IgE is a major component of total serum IgE in dogs. In humans, infection with nematodes, including Toxocara spp., can markedly increase total IgE levels. 10, 11, [38] [39] [40] This study also suggests that the absence of regular deworming does not explain the high total IgE levels detected in dogs. However, this could be explained by the observation that under experimental conditions, dogs repeatedly inoculated with embryonated T. canis eggs and treated with milbemycin still demonstrate a strong antibody response against T. canis L3 E/S antigen without developing patent infections. 24 Deworming does not eliminate extra-intestinal larval infection and dogs can be re-infected soon after treatment. 17, 22, 41 Furthermore, helminth-specific IgE and IgG levels may persist at an elevated level for a significant period of time even after anthelmintic therapy, as demonstrated in humans. 39, 42 In the majority of previously published studies total IgE concentrations between atopic and healthy animals did not differ (Table 1 ). In humans, by contrast, high total IgE levels are evidence for atopic disease in patients living in industrialized countries. 8, 9, 43 Non-atopic humans living in helminth-endemic areas, however, often have total IgE levels elevated above those of healthy people in developed western countries. 40, 44 It is speculated that in dogs the lack of correlation between total IgE levels and atopy could be explained by the frequent infection with helminths resulting in higher total IgE levels masking more subtle increases in allergen-specific IgE. 7, 45 This is contradicted by other studies demonstrating that atopic dogs have significantly higher total IgE levels than healthy dogs. 33 The present study demonstrated significantly higher total IgE concentrations in non-atopic compared to atopic dogs; this has been demonstrated previously only in two other studies. 35, 46 Increased IgE levels in healthy dogs could be the result of two things: the presence of anti-IgE antibodies in atopic dogs, which could interfere with the detection of IgE due to the formation of antibody complexes; 27, 47 or the presence of helminth infections and/or helminth-specific antibodies protecting dogs against the development of atopy. The latter is supported by the present study in the positive correlation between T. canis-specific IgE and total IgE levels. The protective effect of T. canis could arise subsequent to T. canisspecific IgE binding to the surface and enhancing survival time of mast cells. 48 In the absence of exposure to Toxocara, mast cells may bind allergen-specific IgE in place of parasite related IgE; this may make some dogs more prone to showing signs of allergic skin disease. The protective effect of T. canis also could be explained by an immunosuppressive mechanism of helminth proteins. 49 In the present study, non-atopic dogs also demonstrated higher values of T. canis-specific IgG than atopic dogs. It is feasible that healthy dogs may have been exposed more frequently to T. canis than atopic dogs, although given the selection criteria for this study, this seems less likely. A more plausible explanation is that healthy dogs produce more antibodies after exposure to T. canis compared to atopic dogs and that high levels of T. canis-specific serum immunoglobulins protect against the development of cAD. In recent years, the 'hygiene' hypothesis has suggested that the increase in allergic diseases in humans from industrialized countries can be explained by reduced exposure to infectious agents, symbiotic micro-organisms and parasites during the first years of life. 50 In this context, helminth parasitism has been described to have both positive and negative effects on the development of atopic diseases in humans. [51] [52] [53] It has been speculated that the response to parasite exposure varies depending on the species involved, the chronicity of the parasite infection, the parasite burden and/or the age of the infected individual. 54, 55 A significant positive correlation between the ratio of allergen-specific IgE to total IgE and the outcome of food challenge has been reported in humans with suspected milk, egg and wheat allergy. 56 In humans allergic to cat and house dust mite antigens, the ratio negatively correlated with total IgE concentrations, even though there was a tendency to higher allergen-specific IgE levels with increasing total IgE concentrations among the patients with a positive IgE test. 57 No significant difference was detected in the ratio of allergen-specific IgE to total IgE between atopic and non-atopic dogs in the present study. Besides significantly higher total IgE and allergen-specific IgE levels, non-atopic dogs also showed increased T. canis-specific IgE values. This raises the question as to whether some helminth-specific IgE may recognize allergens and lead to an overestimation of allergen-specific IgE levels in allergen tests. In humans living in helminthendemic areas, allergen-specific IgE serologic testing has limited diagnostic value for allergic disease. 58 However, allergen-specific IgE values were measured in only 20 atopic and 13 non-atopic dogs in this study, and therefore the results should be interpreted cautiously.
There are intrinsic and extrinsic factors that reportedly influence total or allergen-specific IgE concentrations in the sera of dogs, 14, 31, [59] [60] [61] [62] although not all studies support these findings. 29, 35, 46 The present study did not demonstrate any correlation between age, gender, vaccination status or recent desensitization and total IgE concentrations. No correlation between the season or previous treatment with immunomodulatory drugs and total IgE levels in dogs was demonstrated.
In summary, the present study compared total IgE, T. canis-specific IgG, T. canis-specific IgE and allergenspecific IgE levels, in atopic and non-atopic dogs, and demonstrated that total IgE concentrations, T. canis-specific IgG and IgE levels, and total allergen-specific IgE values are increased in non-atopic dogs. Furthermore, this study demonstrated a positive correlation between T. canis-specific IgG and T. canis-specific IgE; T. canisspecific IgG and total IgE; T. canis-specific IgE and total IgE; and total IgE and allergen-specific IgE. This could suggest that T. canis-specific IgE is a major component of total IgE in dogs. Furthermore, high quantities of parasite-specific IgE could mask subtle but significant differences in total IgE concentration between allergic and healthy dogs. It is hypothesized that nematode infection could have a protective role against the development of atopic dermatitis in dogs. elev es chez les chiens non-atopiques compar es aux chiens atopiques. Il est suppos e que l'infection par T.canis pourrait avoir un effet contre le d eveloppement de la dermatite atopique canine et ou que l' el evation des taux d'IgE s eriques totaux sont souvent non-associ es a la dermatite atopique.
